Hartford Courant (Sunday)

COURTROOM BATTLES ARE NOT ENOUGH

The dangerous opinion of a Texas-based federal judge

- By William Tong and Joshua Perry

We just got back from a deeply meaningful delegation to Israel, a sister democracy whose residents pour into the streets every night to protest an attempted political takeover of an independen­t judiciary. We came home to our own judicial crisis. But here, the political takeover has been implanted in the judiciary itself.

In Israel this spring, hundreds of thousands of demonstrat­ors have been protesting the coalition government’s plan to neuter judicial review and seize completely control over judicial appointmen­ts. We stood with the demonstrat­ors because we share their belief in the importance of an independen­t judiciary as a check on raw political power and a firewall to protect minority rights.

As their ubiquitous symbol, the protesters have adopted the Israeli flag. They understand that patriotism demands resistance to attacks on judicial independen­ce and that liberty demands equal justice under law.

Here in the United States, an emergent crisis threatens our own constituti­onal order. The question is whether we will have the fortitude and patriotism to confront it.

The latest and one of the most troubling manifestat­ions of that crisis: On April 7, a Texas-based federal judge, Matthew Kacsmaryk, handed down one of the most dangerous opinions that either of us has ever read. It is shamelessl­y wrong in every way an opinion can be wrong — on procedure, substance, science.

In Alliance for Hippocrati­c Medicine v. FDA, anti-abortion zealots asked Kacsmaryk to order the Food and Drug Administra­tion to withdraw its approval of mifepristo­ne, a medication used for abortions and miscarriag­e management.

The FDA approved mifepristo­ne 23 years ago, and it has been used 5.6 million times since then with a vanishingl­y small rate of complicati­ons. It has proven safer than Tylenol and Viagra. And today, most abortions in the country use mifepristo­ne together with another medication, misoprosto­l.

But Kacsmaryk gave the zealots what they wanted, ordering the FDA to suspend its approval of mifepristo­ne within seven days. Never mind that suits like this one need to be brought within six years of approval — not a full generation later. Never mind that these plaintiffs should not have made it through the courthouse doors because they cannot show that the decision injured them. They are doctors who oppose choice, not patients who have actually taken mifepristo­ne.

Principled conservati­ve judges are supposed to care about doctrines like these — statutes of limitation­s and standing. And the conservati­ve Supreme Court majority promised that the end of Roe just meant returning abortion to the states. But Kacsmaryk’s decision, if it takes effect — and it still has not, since the U.S. Supreme Court put it on hold until at least Wednesday, April 19 —would prevent women anywhere in the country, even in states like Connecticu­t where abortion remains legal, from using mifepristo­ne

Kacsmaryk just brushed states’ rights and other ostensibly conservati­ve legal doctrines aside, because he was eager to get to the utterly unscientif­ic and profoundly troubling claim that mifepristo­ne “starves the unborn human until death.” This is ideology

untroubled by legal analysis.

The rest of the decision goes the same way. It valorizes junk science; embraces the dangerous lie that medication abortion psychologi­cally scars women more than forced pregnancy would; and even revives 1873’s Comstock Act, a dead letter since the 1930s, in service of forcing one cramped vision of morality on everyone everywhere in the country.

The opinion is dangerous, but it is not the law in Connecticu­t, where abortion remains legal and mifepristo­ne remains available. The Attorney General’s Office is fighting back. We have already filed a friend-of-the-court brief supporting the FDA’s appeal, which on Friday was at the U.S. Supreme Court. And we are leading with way, with 16 other states and Washington DC, in a lawsuit that has secured a court order compelling FDA to stay the course and continue to make mifepristo­ne available in Connecticu­t.

Courtroom battles are important — but they are not enough.

Our federal judiciary is in crisis. As in Israel, we need mass public engagement to protect our democracy. We need to demand a balanced judiciary, responsive to our nation’s core ideals. That means, among other things, new rules that prevent plaintiffs like these from shopping around for the right reactionar­y judge, and that bar a single judge from inflicting a radical, misogynist­ic ideology on the entire country. It also means strict ethics and disclosure rules to keep moneyed interests from taking judges captive.

We are not naïve. We know that, too often, law is just the secret language of power. Too often, the U.S. judiciary has fallen short of our national ideals. Decisions like Dredd Scott and Korematsu — and Dobbs, too — shame our judiciary and our country.

But we are not yet cynical, either. There is no alternativ­e but to link arms with peaceful protesters in Israel and across the world to recall the law, the judiciary and the country to its fundamenta­l promise.

We are committed to fighting in court — everywhere we can — to protect women’s rights and reproducti­ve freedom. But this is not just a courtroom battle. It is a fight about the kind of country we want to live in, with a judiciary committed to equal justice under law.

 ?? AP 2017 ?? Matthew Kacsmaryk, a Texas judge who has sparked a legal firestorm with an unpreceden­ted ruling halting approval of the nation’s most common method of abortion, is a former attorney for a religious liberty legal group with a long history pushing conservati­ve causes.
AP 2017 Matthew Kacsmaryk, a Texas judge who has sparked a legal firestorm with an unpreceden­ted ruling halting approval of the nation’s most common method of abortion, is a former attorney for a religious liberty legal group with a long history pushing conservati­ve causes.

Newspapers in English

Newspapers from United States